Amol Akhade, Senior Consultant Medical Oncologist and Hemato-Oncologist at Suyog Cancer Clinics and Reliance Hospitals, shared a post on X:
“Will abemaciclib get approved for advanced dedifferntiated liposarcoma after ASCO26?
Probably yes – as it is rare cancer. Placebo on control arm is red flag – as was discussed in question and answer session.
Over all, something to use for those patients who can not take cytotoxic chemotheraphy.”
Other articles featuring Dr. Akhade on OncoDaily.